Pharmacotherapeutic monitoring in elderly and hypertensive patients in a community pharmacy in Northeast Brazil: A pilot study

• Autor(a) principal: dos Santos Silva, Juliana
• Data de Publicação: 2023
• Outros Autores: Oliveira Silva, Noemí, de Jesus Pastor, Edjane, Dantas Oliveira, Isabela Sofia, Santana Santos, Aline, Santos Souza, Carlos Adriano
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1095
• topic: Cuidado farmacêutico; Idosos; Hipertensão arterial; Pharmaceutical care; Elderly; Arterial Hypertension

The pharmaceutical consultation aims to significantly control chronic comorbidities, through monitoring and basic care, based on health education and communication principles. In this context, Systemic Arterial Hypertension (SAH) is defined as systolic BP greater than or equal to 140 mmHg and diastolic BP greater than or equal to 90 mmHg. The objective of the study was to carry out pharmacotherapeutic follow-up in patients over 60 years of age, with SAH, in a community pharmacy in northeastern Brazil. This is an intervention study to monitor patients, using a checklist adapted from Abdel-tawab et al., (2010), with the aid of the Adherence to Refills and Medications Scale (ARMS) to classify adherence. The study was carried out in a community pharmacy in the city of Fátima-BA. After observing the object of study, it can be seen that most patients were female, retired, married and had incomplete primary school; regarding the percentage description of the variation in patients' adherence, most had good adherence (52.38%). Patients have other chronic diseases concomitant with SAH, as the highest percentage was dyslipidemia (33.3%) and type II diabetes (28.5%). With regard to agreed actions, the main conducts were health education (100%), home monitoring of arterial hypertension (85.71%) and requesting laboratory tests (66.66%). Thus, it was possible to carry out pharmaceutical services, in order to use educational measures to improve the patient's quality of life and optimize pharmacotherapy, respecting the subject's integrity.